Riccardo Perfetti

Riccardo Perfetti, listed as senior executive, appears in our data through filings on Applied Therapeutics Inc. shares, published by SEC (Form 4). In total, 20 filings cover trades dated from 11 May 2021 to 4 March 2025.

Market trades split into 1 purchase (€21k) and 8 sales (€842k). Taken together, the sales exceed the purchases by €821k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants and 7 option exercises. 2025 to date brings no purchases and 2 sales.

The latest filing, published on 6 March 2025, reports an open-market sale of €4,350 in Applied Therapeutics Inc. The last purchase on record was published on 23 March 2022, which is 1,670 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.